l carnitine hepatic encephalopathy Effect of treatment with lactulose,

Trial candidates are generally adults with type 2 diabetes and a BMI over 30 who have not achieved adequate glucose or weight control with standard therapies like metformin or a single GLP-1 agonist

In the US, these include the Orphan Drug Act, enacted over 40 years ago to encourage development of treatment for rare (or orphan) diseases

Combining them in a single vial, like in our popular Wolverine Peptide Stack, provides researchers with a convenient tool for investigating these synergistic pathways

Rhoads J

The challenge of reducing the disease burden arises from different factors, including the influence of different comorbidities, mainly those that affect the quality of inflammatory responses, such as HIV ( DM is a chronic metabolic disorder that represents a dramatically high burden to healthcare systems worldwide